What Researchers Did
Researchers randomly assigned 36 patients with radiation-induced hemorrhagic cystitis to receive either intravesical hyaluronic acid instillation or hyperbaric oxygen therapy to compare their efficacy.
What They Found
The study found no statistical difference in overall improvement rates between the hyaluronic acid (HA) and hyperbaric oxygen (HBO) groups at 6, 12, and 18 months post-treatment. Both treatments significantly reduced pelvic pain for 18 months; however, while frequency decreased significantly in both groups at 6 months, only the HA group maintained this significance at 12 months, with HA being well tolerated.
What This Means for Canadian Patients
Canadian patients suffering from radiation-induced hemorrhagic cystitis may consider intravesical hyaluronic acid as an effective and well-tolerated treatment option. This treatment could offer sustained relief from symptoms like bladder bleeding, pelvic pain, and frequent voiding for at least 12 months, similar to hyperbaric oxygen.
Canadian Relevance
This study has no direct Canadian connection as it was not conducted in Canada, nor did it involve Canadian researchers or patients.
Study Limitations
A limitation of this study is its relatively small sample size of 36 patients, which may limit the generalizability of the findings.